WeissComm Partners

[http://www.weisscommpartners.com WeissComm Partners] is a public relations agency serving biotechnology, pharmaceutical, device and diagnostic companies, working with clients from its offices in San Francisco, New York and London. The company specializes in healthcare marketing, corporate and product PR, investor and advocacy relations, and direct-to-patient PR programs that aim to expedite clinical trial recruitment.

Founding

The company was founded by President and CEO Jim Weiss, who previously served as senior director of corporate communications and investor relations at medical device start-up, Heartport, Inc.; director of worldwide product communications at Rhône-Poulenc Rorer Inc. (now Sanofi-Aventis); senior manager of corporate communications at biopharmaceutical firm, Genentech, Inc.; and a PR program developer for GTFH Public Relations and the healthcare PR division of Grey Advertising, Hill & Knowlton, and Ketchum.

WeissComm Partners ranked #57 in public relations magazine PRWeek’s 2006 Agency Rankings. The company posted revenues of $5.8 million in 2005.